RFID Pharmaceutical Tracking Pilot Rolls Out
This week saw the announcement of four companies rolling out what is considered the first commercial electronic pedigree program for pharmaceuticals.
This week saw the announcement of four companies rolling out what is considered the first commercial electronic pedigree program for pharmaceuticals.
Asia’s cultural, political and economic diversity makes it unlikely that RFID privacy issues will emerge here as they have in the West.
In Latin America, privacy takes a backseat to economic growth and personal advancement.
RFID could help reduce counterfeiting and improve patient safety, but the costs are high and there are technological and privacy hurdles to overcome.
The two companies have designed an open drug-authentication model that combines 13.56 MHz RFID technology and a public key infrastructure (PKI).
Lest anyone doubt Symbol Technologies’ designs on the RFID space, a CNETAsia interview with the Holtsville, NY, company’s CEO Bill Nuti will set the record straight.
The prescription drug manufacturer will use RFID to track and authenticate bottles of OxyContin as they move through the supply chain—from factory to pharmacy.
A number of the state’s deer and elk farms will try out UHF RFID readers and tags to identify and inventory their livestock, and possibly to control the spread of disease.
The U.S. Government Accountability Office this month released a report on RFID which broadly and, at about 30 pages, concisely discusses most aspects of RFID and its associated applications and issues.